Company Search:
Advanced Search
Sponsored Links
Green Cross Corporation Company Snapshot
Green Cross Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Green Cross with three other companies in this sector in South Korea: Celltrion, Incorporation (2017 sales of 949.08 billion Korean Won [US$839.94 million] of which 87% was Bio Business Division), Samsung Biologics Co Ltd (464.63 billion Korean Won [US$411.20 million] of which 100% was Biological Medicine Production), and Celltrion HealthCare Co Ltd (920.92 billion Korean Won [US$815.02 million] ).

Sales Analysis. Green Cross reported sales of 1.29 trillion Korean Won (US$1.14 billion) for the year ending December of 2017. This represents an increase of 7.5% versus 2016, when the company's sales were 1.20 trillion Korean Won. Sales at Green Cross have increased during each of the previous five years (and since 2012, sales have increased a total of 59%). Sales of Greencross Genome saw an increase that was more than double the company's growth rate: sales were up 43.9% in 2017, from 5.14 billion Korean Won to 7.40 billion Korean Won. Green Cross also saw significant increases in sales in Greencross Ms (up 13.9% to 98.11 billion Korean Won) and Gcjbp (up 23.0% to 45.07 billion Korean Won) . Not all segments of Green Cross experienced an increase in sales in 2017: sales of Invacfarm fell 9.6% to 14.75 billion Korean Won. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Green Cross Corporation
  Stock Performance Chart for Green Cross Corporation
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 138,000
(Figures in Korean Won)
1 Week -2.8%   13 Weeks 0.0%  
4 Weeks -29.6%   52 Weeks -34.4%  
Green Cross Corporation Key Data:
  Ticker: 006280 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 1,287,916,286,216
(Year Ending Jan 2018).
Employees: 1,766
  Currency: Korean Won Market Cap: 1,575,018,564,000
  Fiscal Yr Ends: December Shares Outstanding: 11,413,178
  Share Type: Common Closely Held Shares: 6,208,447
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.